183 related articles for article (PubMed ID: 23868890)
1. The effectiveness of a perioperative smoking cessation program: a randomized clinical trial.
Lee SM; Landry J; Jones PM; Buhrmann O; Morley-Forster P
Anesth Analg; 2013 Sep; 117(3):605-613. PubMed ID: 23868890
[TBL] [Abstract][Full Text] [Related]
2. Long-term quit rates after a perioperative smoking cessation randomized controlled trial.
Lee SM; Landry J; Jones PM; Buhrmann O; Morley-Forster P
Anesth Analg; 2015 Mar; 120(3):582-587. PubMed ID: 25695576
[TBL] [Abstract][Full Text] [Related]
3. Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trial.
Simon JA; Carmody TP; Hudes ES; Snyder E; Murray J
Am J Med; 2003 May; 114(7):555-62. PubMed ID: 12753879
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a Pilot Perioperative Smoking Cessation Program: A Pre-Post Study.
Young-Wolff KC; Adams SR; Fogelberg R; Goldstein AA; Preston PG
J Surg Res; 2019 May; 237():30-40. PubMed ID: 30694789
[TBL] [Abstract][Full Text] [Related]
5. Predicting smoking cessation. Who will quit with and without the nicotine patch.
Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study).
Cabezas C; Advani M; Puente D; Rodriguez-Blanco T; Martin C;
Addiction; 2011 Sep; 106(9):1696-706. PubMed ID: 21561497
[TBL] [Abstract][Full Text] [Related]
7. Varying nicotine patch dose and type of smoking cessation counseling.
Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
[TBL] [Abstract][Full Text] [Related]
8. A Perioperative Smoking Cessation Intervention With Varenicline, Counseling, and Fax Referral to a Telephone Quitline Versus a Brief Intervention: A Randomized Controlled Trial.
Wong J; Abrishami A; Riazi S; Siddiqui N; You-Ten E; Korman J; Islam S; Chen X; Andrawes MSM; Selby P; Wong DT; Chung F
Anesth Analg; 2017 Aug; 125(2):571-579. PubMed ID: 28319515
[TBL] [Abstract][Full Text] [Related]
9. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
[TBL] [Abstract][Full Text] [Related]
10. A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial.
Wong J; Abrishami A; Yang Y; Zaki A; Friedman Z; Selby P; Chapman KR; Chung F
Anesthesiology; 2012 Oct; 117(4):755-64. PubMed ID: 22890119
[TBL] [Abstract][Full Text] [Related]
11. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
[TBL] [Abstract][Full Text] [Related]
12. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation.
Davidson M; Epstein M; Burt R; Schaefer C; Whitworth G; McDonald A
Arch Fam Med; 1998; 7(6):569-74. PubMed ID: 9821833
[TBL] [Abstract][Full Text] [Related]
14. Interventions for preoperative smoking cessation.
Thomsen T; Villebro N; Møller AM
Cochrane Database Syst Rev; 2010 Jul; (7):CD002294. PubMed ID: 20614429
[TBL] [Abstract][Full Text] [Related]
15. Transdermal nicotine therapy and primary care. Importance of counseling, demographic, and participant selection factors on 1-year quit rates. The Nebraska Primary Practice Smoking Cessation Trial Group.
Daughton D; Susman J; Sitorius M; Belenky S; Millatmal T; Nowak R; Patil K; Rennard SI
Arch Fam Med; 1998; 7(5):425-30. PubMed ID: 9755734
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients.
Molyneux A; Lewis S; Leivers U; Anderton A; Antoniak M; Brackenridge A; Nilsson F; McNeill A; West R; Moxham J; Britton J
Thorax; 2003 Jun; 58(6):484-8. PubMed ID: 12775857
[TBL] [Abstract][Full Text] [Related]
17. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
[TBL] [Abstract][Full Text] [Related]
18. Combining intensive practice nurse counselling or brief general practitioner advice with varenicline for smoking cessation in primary care: study protocol of a pragmatic randomized controlled trial.
van Rossem C; Spigt M; Smit ES; Viechtbauer W; Mijnheer KK; van Schayck CP; Kotz D
Contemp Clin Trials; 2015 Mar; 41():298-312. PubMed ID: 25657051
[TBL] [Abstract][Full Text] [Related]
19. Weight change after smoking cessation using variable doses of transdermal nicotine replacement.
Dale LC; Schroeder DR; Wolter TD; Croghan IT; Hurt RD; Offord KP
J Gen Intern Med; 1998 Jan; 13(1):9-15. PubMed ID: 9462489
[TBL] [Abstract][Full Text] [Related]
20. Nicotine replacement therapy for smoking cessation.
Stead LF; Perera R; Bullen C; Mant D; Hartmann-Boyce J; Cahill K; Lancaster T
Cochrane Database Syst Rev; 2012 Nov; 11():CD000146. PubMed ID: 23152200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
